MiMedx Group (MDXG)
(Delayed Data from NSDQ)
$6.43 USD
-0.08 (-1.23%)
Updated Apr 24, 2024 03:59 PM ET
After-Market: $6.45 +0.02 (0.31%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBalance Sheet
Fiscal Year End for MiMedx Group, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 82 | 66 | 87 | 96 | 69 |
Receivables | 54 | 44 | 41 | 45 | 32 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 21 | 13 | 11 | 10 | 9 |
Other Current Assets | 7 | 11 | 9 | 9 | 13 |
Total Current Assets | 164 | 134 | 149 | 161 | 123 |
Net Property & Equipment | 7 | 8 | 9 | 11 | 12 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 41 | 0 | 0 | 0 | 0 |
Intangibles | 25 | 26 | 25 | 26 | 28 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 239 | 171 | 188 | 202 | 167 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 9 | 9 | 7 | 9 | 9 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 4 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 32 | 33 | 33 | 49 | 53 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 5 | 2 | 2 | 1 | 1 |
Total Current Liabilities | 46 | 44 | 42 | 59 | 67 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 48 | 49 | 48 | 48 | 62 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 2 | 5 | 5 | 4 | 4 |
Minority Interest (Liabilities) | 0 | 92 | 92 | 92 | 0 |
Total Liabilities | 96 | 189 | 188 | 202 | 133 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 276 | 174 | 166 | 159 | 147 |
Retained Earnings | -134 | -192 | -162 | -151 | -102 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 4 | 7 | 11 |
Total Shareholder's Equity | 143 | -18 | 0 | 0 | 34 |
Total Liabilities & Shareholder's Equity | 239 | 171 | 188 | 202 | 167 |
Total Common Equity | 143 | -18 | 0 | 0 | 34 |
Shares Outstanding | 146.20 | 113.60 | 112.10 | 111.00 | 110.70 |
Book Value Per Share | 0.98 | -0.16 | 0.00 | 0.00 | 0.31 |
Fiscal Year End for MiMedx Group, Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 82 | 81 | 69 | 61 |
Receivables | NA | 54 | 49 | 49 | 45 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 21 | 19 | 17 | 15 |
Other Current Assets | NA | 7 | 5 | 7 | 11 |
Total Current Assets | NA | 164 | 155 | 141 | 132 |
Net Property & Equipment | NA | 7 | 7 | 7 | 8 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 41 | 0 | 0 | 0 |
Intangibles | NA | 25 | 25 | 25 | 26 |
Deposits & Other Assets | NA | 0 | 0 | 0 | 0 |
Total Assets | NA | 239 | 189 | 176 | 168 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 9 | 9 | 8 | 8 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 32 | 33 | 34 | 31 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 5 | 2 | 2 | 2 |
Total Current Liabilities | NA | 46 | 44 | 44 | 41 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 48 | 49 | 49 | 0 |
Long-Term Debt | NA | 0 | 0 | 0 | 49 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 3 | 3 | 4 | |
Minority Interest (Liabilities) | NA | 0 | 92 | 92 | 92 |
Total Liabilities | NA | 96 | 188 | 189 | 186 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 276 | 188 | 183 | 179 |
Retained Earnings | NA | -134 | -187 | -196 | -197 |
Other Equity | NA | 0 | 0 | 0 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 143 | 1 | -13 | -18 |
Total Liabilities & Shareholder's Equity | NA | 239 | 189 | 176 | 168 |
Total Common Equity | 0 | 143 | 1 | -13 | -18 |
Shares Outstanding | 146.90 | 146.20 | 116.30 | 116.10 | 115.60 |
Book Value Per Share | 0.00 | 0.98 | 0.01 | -0.11 | -0.16 |